New app-based obesity treatment takes on gold standard in head-to-head trial
NCT ID NCT04708769
First seen May 08, 2026 · Last updated May 08, 2026
Summary
This study compares a new, remotely delivered weight-loss program (EVO) to the standard Diabetes Prevention Program (DPP) in adults with obesity (BMI 30-45). Researchers want to see which program helps people lose more weight over 6 months and which is more cost-effective. Participants use a smartphone app and attend video calls with study staff.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northwestern University
Chicago, Illinois, 60611, United States
Conditions
Explore the condition pages connected to this study.